On February 18, 2025, Celanese Corp (CE, Financial) released its 8-K filing detailing its financial results for the fourth quarter and full year 2024. The company, a leading global producer of acetic acid and specialty polymers, reported a U.S. GAAP diluted loss per share of $13.86 for the year, with adjusted earnings per share of $8.37. This performance exceeded the annual analyst estimate of $4.81 EPS but fell short of the $10,280.63 million in revenue.
Celanese Corp (CE, Financial) is a major player in the chemical industry, known for its production of acetic acid and specialty polymers used across various sectors such as automotive, electronics, and consumer goods. The company also manufactures cellulose derivatives for cigarette filters.
Celanese Corp (CE, Financial) faced a challenging year with net sales of $10.3 billion, a 6% decrease from the previous year. The decline was attributed to a 4% drop in prices and a 1% decrease in volume, compounded by weak demand in key markets like automotive and construction. The company reported a consolidated operating loss of $697 million, highlighting the impact of these market conditions.
Despite the challenges, Celanese achieved an adjusted EBIT of $1.6 billion and operating EBITDA of $2.4 billion, with margins of 16% and 23%, respectively. These metrics are crucial for the chemical industry as they indicate the company's ability to manage costs and maintain profitability in a tough market environment.
| Metric | Q4 2024 | Q3 2024 | Q4 2023 |
|---|---|---|---|
| Net Sales | $2.4 billion | $2.6 billion | $2.6 billion |
| Operating Loss | $(1.4) billion | $248 million | $259 million |
| Adjusted EPS | $1.45 | $2.44 | $2.24 |
The fourth quarter saw a 10% sequential decline in net sales to $2.4 billion, driven by a 7% decrease in volume and a 2% drop in price. The company faced amplified seasonality in its Acetyl Chain and severe destocking in Engineered Materials. These factors contributed to an operating loss of $1.4 billion for the quarter.
The fourth quarter results developed largely as we expected, despite further demand deterioration that gave no sign of easing," said Scott Richardson, President and CEO. "With little indication of near-term recovery, it is our job to drive productivity and earnings growth at Celanese even if fundamental demand remains flat or declines further."
Celanese is focusing on cost reductions and aligning production with demand to stabilize earnings and generate cash for deleveraging. The company announced the completion of actions to exceed $75 million in cost reductions for 2025 and plans to close its Luxembourg Mylar Specialty Films operations. These strategic moves aim to enhance productivity and focus on growth areas like electric vehicles and medical applications.
For more detailed insights and analysis, visit GuruFocus.com.
Explore the complete 8-K earnings release (here) from Celanese Corp for further details.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.